Related Experiment Video
Updated: Sep 28, 2026

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
Safety and immunogenicity of influenza vaccination in individuals infected with HIV
Alessandro R Zanetti1, Antonella Amendola, Silvia Besana
1Institute of Virology, University of Milan, Via Pascal 38, Milan 20133, Italy. alessandro.zanetti@unimi.it
Abstract:
Influenza can cause severe complications in HIV infected individuals leading to increases in hospitalisation and mortality. Vaccination is recommended for such individuals, but some studies reported that immunisation against influenza may stimulate an increase of HIV viral load and decrease of CD4+ cells count. A review of published studies, including our study carried out in HIV former drug addicts, indicates that vaccination against influenza is well tolerated in both children and adult individuals with HIV, but response to vaccination is lower than that observed in immunocompetent individuals. Most studies, including our own, show that vaccination does not induce significant changes in viral load and CD4+ cell counts. In studies reporting modifications of such parameters there is a general agreement that the increased viral replication is usually transient and unable to determine a clear, measurable progression of the underlying HIV disease. Therefore, vaccination against influenza can be safely administered to HIV infected people.
Related Concept Videos
Vaccinations
Inhibitors of Viral Protein Synthesis
Sexually Transmitted Infections
Influenza
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...

